Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1872)	10/15/2003 6:32:38 PM
From: Icebrg	Read Replies (1) of 3044

Apart from the very good sales ramp-up for Velcade there wasn't much to be happy about in the Q3-report. At least not as far as I am concerned. - Integrilin sales have not shown much of an expansion for almost a year now. - Alliance revenues are of a poor quality . - No real signs yet of a reduction in S,G and A resp. R&D costs. - Factor Xa discontinued (It is of course a good thing that they are killing unpromising drug candidates early). - INTEGRILIN ADVANCE-MI clinical trial discontinued. I don't know the significance of that, but I suppose it wasn't good news. The rating must unfortunately be underwhelming for the time being. It will be interesting to see what they have to say to their defense tomorrow. They will have to come down substantially on the operating cost side if they want to meet their 2006 break-even target. But there are no signs that that is happening yet. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next